Literature DB >> 14708685

Mechanisms of action of interferon and nucleoside analogues.

Howard Thomas1, Graham Foster, Dimitris Platis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14708685     DOI： 10.1016/s0168-8278(03)00207-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  16 in total

Review 1.  Gene therapeutic approaches to inhibit hepatitis B virus replication.

Authors:  Maren Gebbing; Thorsten Bergmann; Eric Schulz; Anja Ehrhardt
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Chronic Hepatitis B and C--current treatment and future therapeutic prospects.

Authors:  Christian Müller
Journal:  Wien Med Wochenschr       Date:  2006-07

3.  Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?

Authors:  C John Clements; Ben Coghlan; Mick Creati; Stephen Locarnini; Richard S Tedder; Joseph Torresi
Journal:  Bull World Health Organ       Date:  2009-10-23       Impact factor: 9.408

4.  Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey.

Authors:  Mustafa Sunbul; Hakan Leblebicioglu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 5.  The "return" of hepatitis B.

Authors:  Zahariy-A Krastev
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

6.  Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.

Authors:  Kai-Ling Huang; Yiu-Kay Lai; Chih-Chien Lin; Jia-Ming Chang
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 7.  Detectability and clinical significance of serum hepatitis B virus ribonucleic acid.

Authors:  Yi-Wen Huang; Kazuaki Chayama; Jia-Horng Kao; Sien-Sing Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

8.  Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.

Authors:  Ashrafali Mohamed Ismail; Prasanna Samuel; Jeyamani Ramachandran; Chundamannil Eapen Eapen; Rajesh Kannangai; Priya Abraham
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

9.  Nonresponse to interferon-α based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.

Authors:  Myrna L Cozen; James C Ryan; Hui Shen; Robert Lerrigo; Russell M Yee; Edward Sheen; Richard Wu; Alexander Monto
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

10.  Impact of rtI233V mutation in hepatitis B virus polymerase protein and adefovir efficacy: Homology modeling and molecular docking studies.

Authors:  Ashrafali Mohamed Ismail; Om Prakash Sharma; Muthuvel Suresh Kumar; Rajesh Kannangai; Priya Abraham
Journal:  Bioinformation       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.